Meet Elizabeth

Elizabeth A. Heller, Ph.D., is an Associate Professor at the University of Pennsylvania and Founder of Rafias. Her research focuses on the epigenetic regulation of addiction-related neural circuits, with a particular emphasis on transcriptional mechanisms that drive relapse vulnerability. Dr. Heller’s discoveries around Nr4a1 form the scientific foundation of Rafias’ therapeutic strategy.